CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,142,000 | 4,327,000 | 1,995,000 | 5,394,000 | 2,355,000 |
| Depreciation Amortization | 1,001,000 | 4,224,000 | 3,181,000 | 2,131,000 | 1,049,000 |
| Income taxes - deferred | 155,000 | -2,029,000 | -2,213,000 | -246,000 | -175,000 |
| Accounts receivable | -751,000 | -2,971,000 | -2,009,000 | -2,687,000 | -1,967,000 |
| Accounts payable and accrued liabilities | -1,203,000 | 4,260,000 | 3,350,000 | 2,033,000 | 1,974,000 |
| Other Working Capital | 4,037,000 | 6,818,000 | 12,529,000 | 1,716,000 | 245,000 |
| Other Operating Activity | 2,057,000 | 1,548,000 | 1,296,000 | 665,000 | 82,000 |
| Operating Cash Flow | $7,438,000 | $16,177,000 | $18,129,000 | $9,006,000 | $3,563,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -467,000 | N/A | N/A | -5,010,000 | -904,000 |
| PPE Investments | -984,000 | -2,727,000 | -2,039,000 | -1,459,000 | -1,051,000 |
| Net Acquisitions | -7,094,000 | -1,388,000 | -2,059,000 | -2,068,000 | -7,000 |
| Purchase Of Investment | N/A | -7,746,000 | -6,439,000 | N/A | N/A |
| Sale Of Investment | N/A | 6,729,000 | 5,535,000 | 4,360,000 | N/A |
| Other Investing Activity | 31,000 | 85,000 | 74,000 | 54,000 | -31,000 |
| Investing Cash Flow | $-8,514,000 | $-5,047,000 | $-4,928,000 | $-4,123,000 | $-1,993,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,951,000 | N/A | 0 | 0 | 0 |
| Debt Repayment | -362,000 | -4,211,000 | -4,195,000 | -1,529,000 | -14,000 |
| Common Stock Issued | 96,000 | 551,000 | 510,000 | 348,000 | 297,000 |
| Common Stock Repurchased | -2,018,000 | -3,500,000 | -2,000,000 | -2,000,000 | -2,000,000 |
| Dividend Paid | -779,000 | -2,907,000 | -2,188,000 | -1,462,000 | -722,000 |
| Other Financing Activity | -162,000 | -449,000 | -456,000 | -468,000 | -211,000 |
| Financing Cash Flow | $2,726,000 | $-10,516,000 | $-8,329,000 | $-5,111,000 | $-2,650,000 |
| Beginning Cash Position | 13,305,000 | 12,691,000 | 12,691,000 | 12,691,000 | 12,691,000 |
| End Cash Position | 14,955,000 | 13,305,000 | 17,563,000 | 12,463,000 | 11,611,000 |
| Net Cash Flow | $1,650,000 | $614,000 | $4,872,000 | $-228,000 | $-1,080,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,438,000 | 16,177,000 | 18,129,000 | 9,006,000 | 3,563,000 |
| Capital Expenditure | -984,000 | -2,727,000 | -2,039,000 | -1,459,000 | -1,051,000 |
| Free Cash Flow | 6,454,000 | 13,450,000 | 16,090,000 | 7,547,000 | 2,512,000 |